![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Yale University |
---|---|
Information provided by: | Yale University |
ClinicalTrials.gov Identifier: | NCT00576121 |
This study is designed to look at the measurement and prediction of changes in the heart following a heart attack.
Condition |
---|
Acute Myocardial Infarction |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction |
Estimated Enrollment: | 30 |
Study Start Date: | July 2008 |
Estimated Study Completion Date: | December 2009 |
Groups/Cohorts |
---|
1
Left ventricular ejection fraction (LVEF) patients will be compared at two time-points, 2-5 days and 4 weeks after acute MI.
|
2
End-diastolic volume (LVEDV) patients will be compared at two time-points, 2-5 days and 4 weeks after acute MI.
|
3
End-systolic volume (LVESV) patients will be compared at two time-points, 2-5 days and 4 weeks after acute MI.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Patients will be recruited by a physician referral into the study. Patients will be referred to the study by the cardiologist in the cardiac catheterization lab at Yale New Haven Hospital. Patient recruitment will be limited to patients who are English speakers. Informed consent will be obtained by Dr. Albert Sinusas, MD.
Inclusion Criteria:
Exclusion Criteria:
Contact: Carol Akirav, MSc | 203-785-2429 | carol.akirav@yale.edu |
Contact: Albert J Sinusas, MD | 203-785-3155 | albert.sinusas@yale.edu |
United States, Connecticut | |
Yale New Haven Hospital | |
New Haven, Connecticut, United States, 06520 |
Principal Investigator: | Albert J Sinusas, MD | Yale University |
Responsible Party: | Yale University ( Dr. Albert Sinusas ) |
Study ID Numbers: | 0610001945 |
Study First Received: | December 15, 2007 |
Last Updated: | June 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00576121 |
Health Authority: | United States: Institutional Review Board |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction |
Pathologic Processes Cardiovascular Diseases |